Clinical Research Directory
Browse clinical research sites, groups, and studies.
LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Summary
This study will utilize tissue and peripheral blood samples for proteomics analysis and establish a longitudinal proteomics cohort at multiple critical treatment time points to explore the research value of proteomics in the diagnosis and treatment of lung cancer. The study includes key time points such as screening, postoperative efficacy prediction, and efficacy prediction after medication.
Official title: LcProt: Proteomics Longitudinal Cohort Study on Lung CancerProspective Longitudinal Cohort Study of Lung Cancer Based on Peripheral Blood and Tissue Proteomics
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
2500
Start Date
2019-06-01
Completion Date
2026-12
Last Updated
2025-01-16
Healthy Volunteers
Not specified
Conditions
Interventions
Using tissue and peripheral blood proteomics to distinguish the benign and malignant nature of lung cancer in patients, as well as to evaluate therapeutic efficacy and long-term prognosis during the t
Peripheral blood samples from enrolled participants will be drawn, or lesion tissues will be obtained through procedures such as biopsy or surgery, followed by quantitative proteomics analysis using mass spectrometry.
Locations (1)
the First Affiliated of Guangzhou Medical University
Guangzhou, Guangdong, China